Melbourne, April 9, 2015 - (ABN Newswire) - Rhinomed Ltd (ASX:RNO) Shareholder Update Presentation.
Who is Rhinomed?
- A nasal and respiratory medical technology company based in Melbourne, Australia
- Rhinomed develops, markets and partners it’s internal nasal technology platform into multiple form factors - internal nasal devices!
- Focus is unmet needs in sport & exercise, sleep (snoring, sleep quality and sleep apnea), wellness and drug delivery
To view the shareholder update presentation, please visit: http://media.abnnewswire.net/media/en/docs/ASX-RNO-421733.pdf
WEB: Shareholder Update
About: Rhinomed Ltd
Rhinomed Limited is a medical technology firm that focuses on nasal, respiratory and breathing management technologies. The company is monetising its technology portfolio in the Sport and recreation market, Sleep, Wellbeing and Drug delivery markets.
Rhinomed’s technology is designed to radically improve the way you breathe sleep, maintain your health and take medication.
The first product brought to market is the Turbine(TM). A radical nasal technology that improves airflow by an average of 38%, the Turbine(TM) is an internal nasal dilator that has since it’s launch in January 2014 in Australia, grown to be widely adopted by leading cyclists and triathletes globally.
Now shipped to over 36 countries and with a growing global distribution base, the Turbine(TM) is providing all those undertaking aerobic activities with an opportunity to breathe better, perform better and get more enjoyment from their sport and exercise.
Help employers find you! Check out all the jobs and post your resume.
